DCF — FISHER-TITUS MEDICAL CENTER
Enterprise Value: $-169.6M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-169.6M
Enterprise Value
$-55.2M
PV of Cash Flows
$-114.4M
PV of Terminal Value
$-184.2M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $152.7M | $-9.7M | -6.0% | $-16.2M | $-14.7M |
| Year 2 | $157.3M | $-8.4M | -5.0% | $-15.1M | $-12.5M |
| Year 3 | $162.0M | $-7.1M | -4.0% | $-13.9M | $-10.5M |
| Year 4 | $166.9M | $-6.4M | -4.0% | $-13.5M | $-9.2M |
| Year 5 | $171.9M | $-6.2M | -4.0% | $-13.5M | $-8.4M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-169.6M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$148.3M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.06858998489678739
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5